Med Pharma Incorporated is categorized under Medical and Surgical Services Organizations in Chicago, IL and active since 2007.
Med Pharma Incorporated was established in 2007, and today employs 1 to 4, earning $50.000 to $99.999 per year. This is a Medical and Surgical Services Organizations business, which does work in the B2C market, and is classified as a Medical and Surgical Services Organizations, under code number 621999 by the NAICS.
If you are seeking more information, feel free to contact Peter Czubernat at the company’s single location by writing to 2517 West Devon Avenue, Chicago, Illinois IL 60659 or by phoning (865) 922-3608. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
Business Name: | Med Pharma Incorporated |
Contact Person: | Peter Czubernat |
Address: | 2517 West Devon Avenue, Chicago, Illinois 60659 |
Phone Number: | (865) 922-3608 |
Annual Revenue (USD): | $50.000 to $99.999 |
Founded: | 2007 |
Location Type: | Single Location |
Employee Number: | 1 to 4 |
Business Type: | B2C (Business to Consumer) |
Business Category: | Medical and Surgical Services Organizations |
SIC Code: | 8099 |
NAICS Code: | 621999 |
Share This Business: |
Med Pharma Incorporated was started in 2007 to provide professional Medical and Surgical Services Organizations under the SIC code 8099 and NAICS code 621999. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $50.000 to $99.999 per annum.
Feel free to contact Peter Czubernat for inquiries that concern Med Pharma Incorporated by calling the company number (865) 922-3608, as your correspondence is most welcome. Additionally, the physical location of the single location of Med Pharma Incorporated can be found at the coordinates as well as the street address 2517 West Devon Avenue in Chicago, Illinois 60659.
For its online presence, you may visit Med Pharma Incorporated’s website at and engage with its social media outlets through on Twitter and on Facebook.